Erythromycin enteric-coated tablets have the effect of treating acute bronchitis, acute attack of chronic bronchitis, pharyngitis, tonsillitis, simple skin and soft tissue infections and other diseases. Erythromycin enteric-coated tablets, the active ingredient of which is Erythromycin, belongs to a kind of antimicrobial drugs, which can play an antimicrobial role against pathogens such as Catamorium, Haemophilus influenzae, Streptococcus pyogenes, and so on, and therefore can be used for the treatment of diseases caused by these pathogens, such as acute bronchitis, acute exacerbation of chronic bronchitis, pharyngitis, tonsillitis, and simple skin and soft-tissue infections, and so on. Women during pregnancy and breastfeeding need to be careful with the drug, patients who are allergic to any of the components of the drug in Dirithromycin Enteric-Coated Tablets and patients with potential or suspected bacteremia are forbidden to use the drug for treatment, common adverse developments after the use of the drug are headache, diarrhea, nausea, dyspepsia, dizziness, skin rash and so on. Erythromycin enteric-coated tablets should be used under the guidance of a physician, it is recommended that patients who need to take Erythromycin enteric-coated tablets to the relevant departments of the regular hospital to consult, do not take the drug on their own.